You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Litigation Details for Guardant Health, Inc. v. Tempus AI, Inc. (D. Del. 2024)


✉ Email this page to a colleague

« Back to Dashboard


Biologic Drugs cited in Guardant Health, Inc. v. Tempus AI, Inc.
The biologic drug covered by the patent cited in this case is ⤷  Sign Up .

Details for Guardant Health, Inc. v. Tempus AI, Inc. (D. Del. 2024)

Date Filed Document No. Description Snippet Link To Document
2024-06-11 1 Exhibit A-F 10/2001 Fodor et al . 9,340,830 B2 5/2016 Lipson et al . 6,309,823… 6 / 2001 Salonen 9 , 340, 830 B2 … 10/2001 Fodor et al . 9,340,830 B2 5/2016 Lipson et al. 6,309,823 B1…10/2001 Fodor et al . 9,340,830 B2 5/2016 Lipson et al . 6,309,823… Al 9/2017 Eltoukhy et al. 9,340,830 B2 5/2016 Lipson et al. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.